Stimwave Technologies
Stimwave Technologies filed for Chapter 11 bankruptcy on June 15, 2022, and had certain assets purchased by Curonix LLC on October 31, 2022. The company provides permanently implanted Freedom® PNS and Freedom® SCS devices.
Bankruptcy Filing
Stimwave Technologies filed a voluntary petition for bankruptcy protection under Chapter 11 of the United States Bankruptcy Code. This filing took place in the District of Delaware on June 15, 2022. The Chapter 11 filing allowed the company to reorganize its debts and business affairs.
Asset Acquisition by Curonix LLC
Following the bankruptcy sale, certain assets of Stimwave Technologies were acquired by Curonix LLC. This acquisition took place on October 31, 2022. Post-acquisition, Curonix LLC is responsible for working with physicians to provide ongoing support for previously implanted devices.
Products: Freedom® PNS and Freedom® SCS Devices
Stimwave Technologies provides two types of permanently implanted devices: the Freedom® PNS and Freedom® SCS. These devices are designed to deliver pain management solutions through peripheral nerve stimulation (PNS) and spinal cord stimulation (SCS), respectively.
Ongoing Support by Curonix
Curonix LLC has taken the responsibility to work with physicians to provide ongoing support for the Freedom® PNS and Freedom® SCS devices previously implanted by Stimwave Technologies. This ensures continuity of care and device functionality for patients who have these devices.